Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CST1-Guided Oral Glucocorticoid Therapy for CRSwNP
NCT05598411Phase 4Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Oct 2022
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Oral Glucocorticoids group with Placebo group (2 arms). Primary endpoint: The change in endoscopic polyp score at 26 weeks. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05598411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05598411.